Scholarlink

Purpose <p>Breast cancer affects females from puberty onward, with incidence rates increasing with age. Although metabolic syndrome (MetS) has reportedly increased the incidence of almost all cancers, no clear consensus on the role of MetS in breast cancer development exists. We aimed to clarify the effects of MetS on breast cancer incidence.</p> Methods <p>To investigate this relationship, we analyzed Japanese healthcare data of females from 2005 to 2020 and examined the incidence of breast cancer. MetS was evaluated based on the Japanese criteria or the NCEP ATP III guidelines at enrollment. Of 1,144,791 participants without missing data in our general public cohort, 32,775 with breast cancer at the beginning of the observation period were excluded; 54,330 participants with breast cancer were identified during the observation period.</p> Results <p>Both pre-stage MetS and MetS, defined using the Japanese criteria, were associated with the less frequent incidence of breast cancer (hazard ratios [HRs], 0.90; 95% CI, 0.86–0.94; <i>p</i> &lt; 0.005: HR, 0.83; 95% CI, 0.80–0.87; <i>p</i> &lt; 0.005). Furthermore, MetS using NCEP ATP III was associated with the lower HR (0.87: CI, 0.84–0.90;<i> p</i> &lt; 0.005), and the number of the factors from 1 to 5 was gradually associated with the lower HRs. Analysis according to age group revealed that this observation was the most prominent in the &lt; 50-year-old group.</p> Conclusion <p>MetS is associated with the less frequent breast cancer incidence in females, especially aged &lt; 50&#xa0;years.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Relationship Between the Incidence of Metabolic Syndrome and Breast Cancer

  • 期刊论文

  • 发表日期：

    2025年10月7日

查看全文
  • Naoki Kimoto,
  • Yohei Miyashita,
  • Yutaka Yata,
  • Takeshi Aketa,
  • Masami Yabumoto,
  • Yasushi Sakata,
  • Takashi Washio,
  • Seiji Takashima,
  • Masafumi Kitakaze

摘要

Purpose

Breast cancer affects females from puberty onward, with incidence rates increasing with age. Although metabolic syndrome (MetS) has reportedly increased the incidence of almost all cancers, no clear consensus on the role of MetS in breast cancer development exists. We aimed to clarify the effects of MetS on breast cancer incidence.

Methods

To investigate this relationship, we analyzed Japanese healthcare data of females from 2005 to 2020 and examined the incidence of breast cancer. MetS was evaluated based on the Japanese criteria or the NCEP ATP III guidelines at enrollment. Of 1,144,791 participants without missing data in our general public cohort, 32,775 with breast cancer at the beginning of the observation period were excluded; 54,330 participants with breast cancer were identified during the observation period.

Results

Both pre-stage MetS and MetS, defined using the Japanese criteria, were associated with the less frequent incidence of breast cancer (hazard ratios [HRs], 0.90; 95% CI, 0.86–0.94; p < 0.005: HR, 0.83; 95% CI, 0.80–0.87; p < 0.005). Furthermore, MetS using NCEP ATP III was associated with the lower HR (0.87: CI, 0.84–0.90; p < 0.005), and the number of the factors from 1 to 5 was gradually associated with the lower HRs. Analysis according to age group revealed that this observation was the most prominent in the < 50-year-old group.

Conclusion

MetS is associated with the less frequent breast cancer incidence in females, especially aged < 50 years.